Co-Diagnostics secures CE Mark for direct saliva SARS-CoV-2 test

By staff writers

June 21, 2021 -- Molecular diagnostics company Co-Diagnostics has secured the CE-IVD Mark for its Logix Smart SARS-CoV-2 direct saliva test.

The test identifies the presence of the RdRp and E genes of SARS-CoV-2 from human saliva samples and eliminates the RNA extraction process, making it less costly and time-consuming, according to the firm.

Co-Diagnostics develops test for mutated COVID-19 strain in U.K.
Co-Diagnostics announced that it has developed a molecular test for mutations that have been associated with a new variant of the coronavirus that has...
Co-Diagnostics gets test kit manufacturing help from Promega
Molecular diagnostics company Co-Diagnostics has tapped Promega for additional manufacturing capacity for its COVID-19 test kits.
Co-Diagnostics garners EUA for COVID-19 test
Co-Diagnostics has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its Logix Smart coronavirus COVID-19 reverse...
Co-Diagnostics coronavirus test gets CE Mark in Europe
Co-Diagnostics announced that its Logix Smart reverse transcription polymerase chain reaction test for the novel coronavirus has received the CE Mark...
Co-Diagnostics raises $10.2M, sells coronavirus tests
Molecular diagnostics company Co-Diagnostics is set to raise $10.2 million in a common stock offering to institutional investors. The company plans...

Copyright © 2021

Last Updated ls 6/21/2021 11:44:12 AM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current